218 related articles for article (PubMed ID: 15214921)
1. A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.
Renkl A; Mockenhaupt M; Technau K; Herouy Y; Norgauer J
Br J Dermatol; 2004 Jun; 150(6):1220-2. PubMed ID: 15214921
[No Abstract] [Full Text] [Related]
2. Treatment failure with rituximab in a patient with pemphigus vulgaris.
Weger W; Aberer E
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
[No Abstract] [Full Text] [Related]
3. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
Morrison LH
J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
[TBL] [Abstract][Full Text] [Related]
4. Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation.
Otto G; Hofmann WJ; Gaweco AS; Seelos R; Herfarth C; Meuer S
Transplant Proc; 1996 Dec; 28(6):3210-1. PubMed ID: 8962244
[No Abstract] [Full Text] [Related]
5. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241
[No Abstract] [Full Text] [Related]
6. A case of Sweet's syndrome and pemphigus vulgaris.
del Pozo J; Martínez W; Carro E; Arévalo MP; Rodríguez-Lozano J; Fonseca E
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):745-6. PubMed ID: 15482319
[No Abstract] [Full Text] [Related]
7. [Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients].
Carl S; Wiesel M; Deiss JM; Daniel V; Opelz G; Staehler G
J Urol (Paris); 1997; 103(1-2):7-9. PubMed ID: 9765770
[No Abstract] [Full Text] [Related]
8. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
Kong HH; Prose NS; Ware RE; Hall RP
Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
[TBL] [Abstract][Full Text] [Related]
9. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
[TBL] [Abstract][Full Text] [Related]
10. Outcome of pemphigus vulgaris.
Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in refractory pemphigus vulgaris.
Sorce M; Aricò M; Bongiorno MR
Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
[TBL] [Abstract][Full Text] [Related]
12. Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy.
Heng YK; Lee JS; Neoh CY
Int J Dermatol; 2012 Sep; 51(9):1044-6. PubMed ID: 22909356
[No Abstract] [Full Text] [Related]
13. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
Arin MJ; Engert A; Krieg T; Hunzelmann N
Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
[TBL] [Abstract][Full Text] [Related]
14. Daclizumab: a novel therapeutic option in severe bullous pemphigoid.
Mockenhaupt M; Grosber M; Norganer J
Acta Derm Venereol; 2005; 85(1):65-6. PubMed ID: 15848995
[No Abstract] [Full Text] [Related]
15. Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody).
Osborne GE; Pagliuca A; Ho A; du Vivier AW
Br J Dermatol; 2006 Sep; 155(3):617-20. PubMed ID: 16911291
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for pemphigus vulgaris in Japan.
Hashimoto T
Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody].
Campana C
Ital Heart J Suppl; 2000 Jun; 1(6):838-9. PubMed ID: 11204021
[No Abstract] [Full Text] [Related]
18. Complete remission of drug-resistant Pemphigus vegetans treated by extracorporeal photopheresis.
Kaiser J; Kaatz M; Elsner P; Ziemer M
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):843-4. PubMed ID: 17567330
[No Abstract] [Full Text] [Related]
19. Recalcitrant pemphigus foliaceus with Kaposi's varicelliform eruption: report of a fatal case.
Demitsu T; Kakurai M; Azuma R; Hiratsuka Y; Yamada T; Yoneda K
Clin Exp Dermatol; 2008 Aug; 33(5):681-2. PubMed ID: 18801107
[No Abstract] [Full Text] [Related]
20. First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus.
Cho YT; Lee FY; Chu CY; Wang LF
Acta Derm Venereol; 2014 Jul; 94(4):472-3. PubMed ID: 24217821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
